Kozak & Associates’s Amgen AMGN Stock Holding History

Kozak & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$175K	Sell	388 -1	-0.3%	-$399	0.03%	77
2026 Q2	$140K	Buy	389 +6	+2%	+$2.05K	0.02%	85
2026 Q1	$134K	Buy	383 +2	+0.5%	+$713	0.03%	85
2025 Q4	$124K	Buy	381 +2	+0.5%	+$634	0.02%	95
2025 Q3	$130K	Buy	379 +2	+0.5%	+$580	0.03%	102
2025 Q2	$112K	Sell	377 -19	-5%	-$5.38K	0.02%	105
2025 Q1	$116K	Buy	396 +24	+6%	+$7.09K	0.03%	95
2024 Q4	$97.1K	Buy	372 +27	+8%	+$8.01K	0.02%	102
2024 Q3	$111K	Buy	345 +87	+34%	+$28.5K	0.03%	100
2024 Q2	$79.8K	Buy	258 +2	+0.8%	+$588	0.02%	104
2024 Q1	$80.6K	Sell	256 -27	-10%	-$7.9K	0.02%	109
2023 Q4	$85.7K	Hold	283	–	–	0.03%	113
2023 Q3	$75.8K	Hold	283	–	–	0.03%	116
2023 Q2	$63.7K	Hold	283	–	–	0.03%	126
2023 Q1	$68.5K	Hold	283	–	–	0.03%	124
2022 Q4	$74K	Hold	283	–	–	0.04%	123
2022 Q3	$70K	Hold	283	–	–	0.04%	123
2022 Q2	$69K	Hold	283	–	–	0.05%	128
2022 Q1	$64K	Hold	283	–	–	0.04%	136
2021 Q4	$64K	Hold	283	–	–	0.04%	136
2021 Q3	$59K	Buy	+283	New	+$65.1K	0.03%	146

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Kozak & Associates's AMGN Position: Q3 2026 in Review

Kozak & Associates reduced its Amgen (AMGN) stake by 0.26% in Q3 2026, selling an estimated $399 and leaving 388 shares worth $175K. The position accounts for 0.03% of the portfolio, ranked #77.

Kozak & Associates first reported a position in AMGN in Q3 2021 and has held it in 21 quarters since. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Kozak & Associates held 388 shares of Amgen worth $175K as of Q3 2026.
Kozak & Associates sold 1 Amgen share in Q3 2026, an estimated $399.
Amgen made up 0.03% of Kozak & Associates's portfolio in Q3 2026, its #77 holding.
Kozak & Associates first reported a position in Amgen in Q3 2021 and has held it in 21 quarters since.
2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Kozak & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.